Replies to post #20829 on Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

The Wolf Says

"The rationale for the merger is that PDI has all rights, patents and trademarks for diagnostic technologies that Radient Pharmaceuticals believes will strengthen and complement its core business. Pursuant to the LOI, Provista will become a wholly-owned subsidiary of Radient Pharmaceuticals."

Columbo Says


Who has all the recent patents, trademarks,ect...Provista Diagnostics DX. THERE IS YOUR PATENTS GENTLEMEN...Not too late to BUY you understand...Wolf

[dcspka]

What I find interesting from the 2010 LOI announcement:

" Provista Diagnostics Inc. is a healthcare and biotechnology development company located in Phoenix, Arizona, that provides innovative tests for early disease detection to medical professionals and patients. The Company's product portfolio includes:

BT Test® - a diagnostic blood test that detects and measures the levels of key biomarkers that are associated with breast cancer.
LymPro Test® - a blood test designed to work with traditional diagnostic methods to assist doctors in a more timely and accurate diagnosis of Alzheimer's disease.
RCP Test® - a diagnostic blood test for the possible presence of ovarian, uterine, and cervical cancer in women.
REDx™ - a diagnostic blood test to screen for Mild Cognitive Impairment, Alzheimer's disease and other forms of dementia."

We know that LymPro was licensed to Amarantus courtesy of William Gartner.

BT test??? RCP Test??? REDx ???

[lakeshore555]

Provista answers emails and their telephone.

Contact them and ask them if they have any plans to work with Radient or use DR-70 or do anything at ALL with Radient, its officers, its products, or its future.

I did. The answer I got would just be hearsay, so instead of repeating it here, I urge anyone and everyone to contact Provista YOURSELF to get the truth right from the source.